Ovid Therapeutics Inc — Quarterly Financial Data (NASDAQ:OVID) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

Notizie

PTC Therapeutics (PTCT) Reports Q4 Loss, Misses Revenue Estimates

Ovid Therapeutics: Bullish Post-PIPE With Two Differentiated CNS Moonshots

L’attivatore KCC2 di Ovid mostra promettente sicurezza in trial iniziale

Ovid’s KCC2 activator shows promising safety in early trial

Gli azionisti di Ovid Therapeutics approvano l’aumento delle azioni autorizzate

Ovid Therapeutics shareholders approve increase in authorized shares and related proposals

Roth/MKM avvia copertura su Ovid Therapeutics con rating Buy per farmaco epilessia

Roth/MKM initiates Ovid Therapeutics stock with Buy rating on epilepsy drug

Ovid Therapeutics appoints Petra Kaufmann as chief medical officer

This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Adverum Biotechnologies (NASDAQ:ADVM), Alto Neuroscience (NYSE:ANRO)

Gli EPS di Ovid Therapeutics hanno mancato le aspettative per 0,02$, il fatturato appena sotto le previsioni

Ovid Therapeutics earnings missed by $0.02, revenue fell short of estimates